Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.2011.605352
Reference106 articles.
1. Sjögren's syndrome
2. Health-related quality of life, employment and disability in patients with Sjögren's syndrome
3. New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers
4. B-cell tolerance breakdown in Sjögren's Syndrome: Focus on BAFF
5. Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Zielgerichtete Immuntherapien beim primären Sjögren-Syndrom;Arthritis und Rheuma;2024-04
2. Role of regulatory T cells in the pathogenesis and therapeutics of primary Sjögren’s syndrome;Regulatory T Cells and Autoimmune Diseases;2024
3. Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease;Scientific Reports;2023-11-09
4. Sjögren’s syndrome: shedding light on emerging and key drug targets;Expert Opinion on Therapeutic Targets;2022-10-03
5. Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome;Arthritis Research & Therapy;2021-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3